Trial Profile
Fludarabine, chlorambucil or fludarabine + chlorambucil as first-line treatment in patients with chronic lymphocytic leukaemia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Apr 2013
Price :
$35
*
At a glance
- Drugs Chlorambucil (Primary) ; Fludarabine (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- 05 Nov 2010 New trial record.